Skip to content
Screener

EyePoint, Inc. EYPT Pre-Tax Income

Pre-Tax Income at other companies

Merck & Co. logo
Merck & Co.MRK
-$683M-114%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.53B+0.6%
HRO
HarrowHROW
-$17.27M-446%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$16.09M+44.3%
Bausch + Lomb logo
Bausch + LombBLCO
-$11M+92.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$6.47M+54.2%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.2B+69.1%
Enterprise value$1.11B+67.9%
P/S429.4×+416×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Other (expense) income:
Interest and other income, net2,9102,8945,2546,536
Total other income, net2,9102,8945,2546,536
Net loss before income taxes$(94,470)$(59,333)$(179,352)$(104,528)
Provision for income taxes(93)50(93)
Net loss$(94,470)$(59,426)$(179,302)$(104,621)
Net loss per share:
Basic and diluted$(1.09)$(0.85)$(2.08)$(1.50)

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s pre-tax income?
EyePoint, Inc. (EYPT) reported pre-tax income of -$94.47M in Q2 2026.
How has EyePoint, Inc.'s pre-tax income changed year-over-year?
EyePoint, Inc.'s pre-tax income decreased by 59.2% year-over-year, from -$59.33M to -$94.47M.
What is the long-term trend for EyePoint, Inc.'s pre-tax income?
Over 4 years (2021 to 2025), EyePoint, Inc.'s pre-tax income has grown at a 41.1% compound annual growth rate (CAGR), from -$58.42M to -$231.68M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about EyePoint, Inc.'s pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude